Skip to main content
. 2011 Jan 28;6(1):e16257. doi: 10.1371/journal.pone.0016257

Figure 2. Monthly prevalence of P. vivax patent, sub-patent infections and of anti-CSP antibodies, and monthly rainfall.

Figure 2